Company Filing History:
Years Active: 2016-2025
Title: Innovations of John Krupinski
Introduction
John Krupinski is a notable inventor based in Flemington, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins. With a total of six patents to his name, Krupinski's work focuses on innovative solutions for treating diseases associated with fibrosis.
Latest Patents
Krupinski's latest patents include groundbreaking inventions such as nucleic acids encoding modified FGF-21 polypeptides. These nucleic acids are designed to express modified FGF-21 polypeptides, which can be utilized as therapeutics in the treatment of fibrosis-related diseases. His patents also cover methods of treating such diseases using these modified polypeptides, which may contain internal deletions and non-naturally-encoded amino acids.
Career Highlights
Krupinski is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative therapeutic options that address critical health challenges.
Collaborations
Throughout his career, Krupinski has collaborated with esteemed colleagues, including Paul E. Morin and Daniel Cohen. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
John Krupinski's contributions to biotechnology and his innovative patents reflect his commitment to improving health outcomes. His work continues to pave the way for new therapeutic approaches in the treatment of fibrosis-related diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.